Immuneering Corporation trades on the NASDAQ exchange under the ticker symbol IMRX, with its common stock valued around five dollars and eighteen cents per share. Because equity valuations fluctuate continuously during active trading hours based on shifting market liquidity, clinical trial announcements, and broader economic sentiment, investors seeking precise, live quotes should check real-time financial feeds or brokerage terminals.